GOLDMAN SACHS GROUP INC - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 139 filers reported holding KRYSTAL BIOTECH INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q3 2023$21,383,904
-6.6%
184,344
-5.4%
0.00%
-20.0%
Q2 2023$22,885,487
+10.9%
194,936
-24.4%
0.01%
+25.0%
Q1 2023$20,644,271
+76.6%
257,860
+74.7%
0.00%
+33.3%
Q4 2022$11,692,952
+17.8%
147,601
+3.7%
0.00%
+50.0%
Q3 2022$9,924,000
-7.7%
142,385
-13.0%
0.00%0.0%
Q2 2022$10,752,000
+18.8%
163,744
+20.4%
0.00%0.0%
Q1 2022$9,053,000
+143.5%
136,047
+156.0%
0.00%
+100.0%
Q4 2021$3,718,000
+234.1%
53,153
+149.3%
0.00%
Q3 2021$1,113,000
-88.0%
21,325
-84.3%
0.00%
-100.0%
Q2 2021$9,238,000
-34.3%
135,858
-25.5%
0.00%
-50.0%
Q1 2021$14,059,000
+8.8%
182,482
-15.2%
0.00%
+33.3%
Q4 2020$12,917,000
+9.1%
215,284
-21.8%
0.00%0.0%
Q3 2020$11,845,000
+0.6%
275,142
-3.3%
0.00%
-25.0%
Q2 2020$11,780,000
+170.4%
284,396
+182.2%
0.00%
+100.0%
Q1 2020$4,357,000
-1.6%
100,764
+26.1%
0.00%
+100.0%
Q4 2019$4,427,000
+1241.5%
79,932
+876.7%
0.00%
Q2 2019$330,000
-67.9%
8,184
-73.8%
0.00%
Q1 2019$1,029,000
+343.5%
31,284
+42.0%
0.00%
Q4 2017$232,000
+17.8%
22,036
+11.3%
0.00%
Q3 2017$197,00019,8000.00%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q2 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 895,000$53,700,0004.14%
S Squared Technology, LLC 85,215$5,113,0002.93%
First Light Asset Management, LLC 491,740$29,504,0002.18%
Redmile Group, LLC 1,675,036$100,502,0001.22%
Nicholas Investment Partners, LP 233,543$14,013,0001.08%
HighMark Wealth Management LLC 17,586$1,055,0000.91%
DSAM Partners (London) Ltd 87,608$5,256,0000.62%
SPHERA FUNDS MANAGEMENT LTD. 101,044$6,063,0000.54%
Hood River Capital Management LLC 261,122$15,667,0000.52%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 9,900$594,0000.45%
View complete list of KRYSTAL BIOTECH INC shareholders